Table 1.
Clinical and biochemical characteristics of the study patients
| Characteristics | Value |
|---|---|
| Age (y) | 54.52±10.63 |
| Sex (M/F) | 36/24 (60.0/40.0) |
| BMI (kg/m2) | 22.63 (202.485–246.62) |
| Systolic blood pressure (mmHg) | 134.70±19.327 |
| Diastolic blood pressure (mmHg) | 76.105±13.22 |
| Underlying disease | |
| Hypertension | 51 (80.00) |
| Diabetes mellitus | 26 (43.33) |
| Angina | 7 (11.67) |
| Peripheral arterial occlusive disease | 9 (15.00) |
| Stroke | 4 (6.67) |
| Smoking | 17 (28.33) |
| Albumin (g/dL) | 3.90 (3.60–4.20) |
| Calcium (mg/dL) | 8.60 (3.60–9.10) |
| Phosphate (mg/dL) | 4.80 (4.253–6.253) |
| PTH (pg/mL) | 122.30 (52.40–210.70) |
| FGF23 (pg/mL) | 1532.12 (423.325–2122.56) |
| Duration of hemodialysis (mo) | 52.00 (20.30–85.50) |
| Duration of access survival (mo) | 26.00 (6.80–60.00) |
| Duration from hemodialysis to first access revision (mo) | 17.00 (2.00–52.00) |
Data are presented as mean±SD, n (%) or median (IQR).
BMI, body mass index; FGF, fibroblast growth factor; IQR, interquartile range; PTH, parathyroid; SD, Standard deviation.